Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Haematologica|March 23, 2023
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasmMarlise R Luskin, Andrew A LaneHematology. American Society of Hematology. Education Program|December 10, 2021
Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy?Marlise R LuskinClinical Lymphoma, Myeloma & Leukemia|January 8, 2022
SOHO State of the Art Updates and Next Questions: Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the FutureMarlise R LuskinHematology. American Society of Hematology. Education Program|December 7, 2024
Ph+ ALL: new approaches for upfront therapyMarlise R LuskinAmerican Journal of Hematology|June 17, 2025
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): 2025 Update on Diagnosis, Pathophysiology, Risk Assessment, and ManagementShai Shimony, Marlise R Luskin, Naseema Gangat, et al.Clinical Lymphoma, Myeloma & Leukemia|December 15, 2023
SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic LeukemiaShai Shimony, Marlise R LuskinHaematologica|June 12, 2025
Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomesMarlise R Luskin, Jessica T LeonardExpert Review of Hematology|October 27, 2017
Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemiaMarlise R Luskin, Daniel J DeAngeloJournal of Geriatric Oncology|January 2, 2018
Management of older adults with myelodysplastic syndromes (MDS)Marlise R Luskin, Gregory A AbelJournal of Geriatric Oncology|February 22, 2018
How to treat chronic myeloid leukemia (CML) in older adultsMarlise R Luskin, Daniel J DeAngeloPageof 20